IP Library Granted Patent US 10,900,176
Granted Patent B2
US 10,900,176 · App. 16/353,160 · Granted Jan 26, 2021

Soft tissue produced using a structured fabric and energy efficient pressing

Inventors: Byrd Tyler Miller, IV (Easley, SC); Justin S. Pence (Anderson, SC); James E. Sealey (Belton, SC)
Assignee: FIRST QUALITY TISSUE, LLC
D21H27/005D21H5/14D21H11/12D21H17/28D21H17/375D21H21/14D21H21/18D21H21/20D21H21/22D21H21/24D21H21/28D21H27/002D21H27/30D21H27/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,900,176
App. No.
16/353,160
Granted
Jan 26, 2021
Kind
B2
Abstract

A structured tissue product produced using a structured or imprinting fabric and a press roll. The tissue product has at least two plies, and has a crumple resistance of less than 30 grams force and an average peak to valley depth of at least 65 microns.

Claims (41)

1. A structured tissue product comprising at least two plies, wherein the structured tissue product has a crumple resistance of less than 30 grams force, a caliper of at least 450 microns/ply, and a softness of 85 TSA to 100 TSA, wherein:

a web that makes up one of the at least two plies comprises a first exterior layer, an interior layer and a second exterior layer;

the interior layer contains a first wet end additive comprising an ionic surfactant and a second wet end additive comprising a non-ionic surfactant; and

wherein the ratio by weight of the first wet end additive to the second wet end additive in the tissue is between one to eight and one to ninety.

2. The structured tissue product according to claim 1 , wherein the structured tissue product has an average peak to valley depth of at least 100 microns.

3. The structured tissue product according to claim 1 , wherein the first exterior layer comprises at least 50% virgin hardwood fibers.

4. The structured tissue product according to claim 1 , wherein the first exterior layer comprises at least 75% virgin hardwood fibers.

5. The structured tissue product according to claim 3 , wherein the virgin hardwood fibers is virgin eucalyptus fibers.

6. The structured tissue product according to claim 1 , wherein the interior layer comprises cannabis fibers in an amount of 1% to 10%.

7. The structured tissue product according to claim 1 , wherein the second exterior layer comprises cannabis fibers in an amount of 1% to 10%.

8. The structured tissue product according to claim 1 , wherein the first exterior layer comprises a wet end temporary wet strength additive.

9. The structured tissue product according to claim 8 , wherein the wet end temporary wet strength additive comprises glyoxalated polyacrylamide.

10. The structured tissue product according to claim 1 , wherein the first exterior layer comprises a wet end dry strength additive.

11. The structured tissue product according to claim 10 , wherein the wet end dry strength additive comprises amphoteric starch.

12. The structured tissue product according to claim 1 , wherein the second exterior layer comprises a wet end dry strength additive.

13. The structured tissue product according to claim 12 , wherein the wet end dry strength additive comprises amphoteric starch.

14. The structured tissue product according to claim 1 , wherein the second wet end additive comprises an ethoxylated vegetable oil.

15. The structured tissue product according to claim 1 , wherein the second wet end additive comprises a combination of ethoxylated vegetable oils.

16. The structured tissue product according to claim 1 , wherein the ionic surfactant comprises a debonder.

17. The structured tissue product according to claim 1 , wherein the first and second exterior layers are substantially free of surface deposited softener agents or lotions.

18. The structured tissue product according to claim 1 , wherein the first exterior layer comprises a surface deposited softener agent or lotion.

19. The structured tissue product according to claim 1 , wherein the non-ionic surfactant has a hydrophilic-lipophilic balance of less than 10.

20. The structured tissue product of claim 1 , wherein the tissue product has a caliper of 450 microns/2 ply to 600 microns/2 ply and is un-calendered.

21. The structured tissue product of claim 1 , wherein the tissue product has a caliper of 600 microns/2 ply to 800 microns/2 ply and is uncalendered.

22. The structured tissue product of claim 1 , wherein the tissue product has a caliper of 500 microns/2 ply to 700 microns/2 ply and is calendered.

23. The structured tissue product of claim 1 , wherein the tissue product has a basis weight in g/m2 per 2 ply of 28 g/m2 to 39 g/m2.

24. The structured tissue product of claim 1 , wherein the tissue product has a machine direction tensile strength per 2 ply of 110 N/m to 190 N/m.

25. The structured tissue product of claim 1 , wherein the tissue product has a cross machine direction tensile strength per 2 ply of 35 N/m to 90 N/m.

26. The structured tissue product of claim 1 , wherein the tissue product has a machine direction stretch of 4% to 30% per 2 ply.

27. The structured tissue product of claim 1 , wherein the tissue product has a cross direction stretch of 4% to 20% per 2 ply.

28. The structured tissue product of claim 1 , wherein the tissue product has a 2-ply cross direction wet tensile strength of 0 to 25 N/m.

29. The structured tissue product of claim 1 , wherein the tissue product has a ball burst strength of 150 gf to 300 gf per 2-ply.

30. The structured tissue product of claim 1 , wherein the tissue product has a lint value of 2.5 to 7.5 per 2 ply.

31. The structured tissue product of claim 1 , wherein the tissue product has a softness of 85 TSA to 100 TSA.

32. The structured tissue product of claim 1 , wherein the bulk softness (TS7) of the tissue product is 10 or less.

33. The structured tissue product of claim 1 , wherein the tissue product has no wet end additives.

34. The structured tissue product of claim 1 , wherein a web that makes up at least one of the two plies contains a glyoxylated polyacrylamide, an amphoteric starch and a debonder.

35. The structured tissue product of claim 1 , wherein the first exterior layer is comprised of 100% eucalyptus fibers.

36. The structured tissue product of claim 1 , wherein the interior layer contains 10% cannabis fibers, 30% northern bleached softwood kraft fibers and 60% eucalyptus fibers.

37. The structured tissue product of claim 1 , wherein the second exterior layer contains 10% cannabis fibers, 20% northern bleached softwood kraft fibers and 70% eucalyptus fibers.

38. The structured tissue product of claim 1 , wherein a web that makes up at least one of the at least two plies is creped at 15% crepe.

Assignments (1)
SECURITY INTEREST Recorded Jan 6, 2022
From: FIRST QUALITY TISSUE, LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 058563/0800 →
Continuity (3)
Continuation 14951121 · Nov 24, 2015
Provisional Application 62083735 · Nov 24, 2014
Related Publication 20190316298A1 · Oct 17, 2019